최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.59 no.6, 2015년, pp.259 - 265
In recent, there are increasing reports about pharmacological activities of Crataegi Fructus which has been used for many centuries as medicinal and food sources in East Asia. However, its antifungal efficacy needs to be investigated. Thus, in the current study, we determined synergistic antifungal ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
진균 감염증 치료용 항생물질의 단점은 무엇인가? | 세균 감염증 뿐만 아니라 진균 감염증으로 인한 문제도 매우 심각한 실정이다. 1-3) 하지만, 진균 감염증 치료용 항생물질의 종류는 세균감염 치료에 사용하는 항생제에 비해서 종류가 다양하지 못할 뿐만 아니라 부작용도 많아서 새로운 항진균제의 개발과 기존의 항진균제를 활용하는 치료요법의 고안이 필요하다. | |
병원성 진균 중에서 가장 많은 문제를 유발하는 진균은 무엇인가? | 병원성 진균 중에서 가장 많은 문제를 유발하는 진균으로는 Candida albicans를 손꼽을 수가 있는데, 최근에는 항진균제에 내성이 있는 C. albicans 균주의 출현으로 인해 이 진균에 의한 감염율이 증가 추세에 있다. | |
C. albicans가 균사를 생성함으로써 야기하는 문제점은? | albicans 기인성 질감염 때문에 고통을 받는다는 보고가 있다. 9,10) 이 진균은 균사(hyphae)를 생성할 수가 있어서 인체 내 거의 모든 장기에 침투가 가능해서 감염증을 악화시키기도 한다. 이런 까닭에 C. |
Bodey, G. P. : The emergence of fungi as major hospital pathogens. J. Hosp. Infect. 11, 411 (1988).
Arturo, C. : Antibodies and fungi: an evolving paradigm with opportunities for the development of new antifungal therapies and vaccines. Rev. Iberoam. Micol. 14, 2 (1997).
Baselski, V. S., Robison, M. K., Pifer, L. W. and Woods, D. R. : Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using cellufluor staining. J. Clin. Microbiol. 28, 393 (1990).
Lee, K. K., Maccallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. and Munro, C. A. : Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob. Agents Chemother. 56, 208 (2012).
Angiolella, L., Stringaro, A. R., De Bernardis, F., Posteraro, B., Bonito, M., Toccacieli, L., Torosantucci, A., Colone, M., Sanguinetti, M., Cassone, A. and Palamara, A. T. : Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob. Agents Chemother. 52, 927 (2008).
Schaberg, D. R., Culver, D. H. and Gaynes, R. P. : Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 16, 72S (1991).
Edwards, J. E. : Invasive Candida infections: evolution of a fungal pathogen. N. Engl. J. Med. 324, 1060 (1991).
Gow, N. A., Brown, A. J. and Odds, F. C. : Fungal morphogenesis and host invasion. Curr. Opin. Microbiol. 5, 366 (2002).
Sobel, J. D. : Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 152, 924 (1985).
Sobel, J. D. : Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544, 547 (1988).
Odds, F. C., Brown, A. J. and Gow, N. A. : Antifungal agents: mechanisms of action. Trends Microbiol. 11, 272 (2003).
Bae, M. H. and Kim, H. H. : Mechanism of Crataegi Fructus extract induced endothelium-dependent vasorelaxation in rabbit carotid artery. Kor. J. Herbology 18, 169 (2003).
Hong, S. S., Hwang, J. S., Lee, S. A., Han, X. H., Ro, J. S. and Lee, K. S. : Inhibitors of monoamine oxidase activity from the fruits of Crataegus pinnatifida Bunge. Kor. J. Pharmacogn. 33, 285 (2002).
An, B. J., Kang, B. Y. and Lee, J. T. : Development of cosmetic material from Korean Crataegi Fructus extract. Kor. J. Herbology 17, 39 (2002).
Lin, H. H., Charles, A. L., Hsieh, C. W., Lee, Y. C. and Ciou, J. Y. : Antioxidant effects of 14 Chinese traditional medicinal herbs against human low-density lipoprotein oxidation. J. Tradit. Complement Med. 5, 51 (2014).
Kao, E. S., Wang, C. J., Lin, W. L., Yin, Y. F., Wang, C. P. and Tseng. T. H. : Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J. Agric. Food. Chem. 53, 430 (2005).
Seo, B. I. : Preventive effects of water extracts from on Crataegi Fructus on hyperlipiderma and liver damage induced by alcohol. Kor. J. Herbology 20, 35 (2005).
Ahn, K. S., Hahm, M. S., Park, E. J., Lee, H. K. and Kim, I. H. : Corosolic acid isolated from the fruit of Crataegus pinnatifida var. psilosa is a protein kinase C inhibitor as well as a cytotoxic agent. Planta Med. 64, 468 (1998).
Chan, A. S., Yip, E. C., Yung, L. Y., Pang, H., Luk, S. C., Pang, S. F. and Wong, Y. H. : Immuno-regulatory effects of CKBM on the activities of mitogen-activated protein kinases and the release of cytokines in THP-1 monocytic cells. Biol. Pharm. Bull. 28, 1645 (2005).
Choi, O. K., Kim, Y., Cho, G. S. and Sung, C. K. : Screening for antimicrobial activity from korean plants. Kor. J. Food. Nutr. 15, 301 (2002).
Ryu, H. Y., Park, S. J., Lee, B. H. and Sohn, H. Y. : Antimicrobial activity of fruit of Crataegus pinnatifida Bunge against multidrug resistant pathogenic Pseudomonas aeruginosa and Candida sp. Kor. J. Micobiol. Biotechnol. 38, 77 (2010).
Qin, R,. Xiao, K., Li, B., Jiang, W., Peng, W., Zheng, J. and Zhou, H. : The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo. Int. J. Mol. Sci. 14, 1802 (2013)
Kim, J., Park, Y. J., Park, K. D., Jung, B., Choi, M. Y. and Han, Y. : Antimicrobial activities of Crataegi Frucutus methanol extract. Dongduk Yakhak Res. 14, 33 (2010).
Park, S. W., Yook, C. S. and Lew, H. K. : Chemical components from the fruits of Crataegus pinnatifida var. psilosa. Kor. J. Pharmacogn. 25, 328 (1994).
Han, Y. and Cutler, J. E. : Antibody response that protects against disseminated candidiasis. Infect. Immun. 63, 2714 (1995).
Han, Y., Morrison, R. P. and Cutler, J. E. : A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66, 5771 (1998).
Lee, J. H., Lee, J. Y., Park, J. H., Jung, H. S., Kim, J. S., Kang, S. S., Kim, Y. S. and Han, Y. : Immunoregulatory activity by daucosterol, a ${\beta}$ -sitosterol glycoside, induces protective Th1 immune response against disseminated candidiasis in mice. Vaccine 25, 3834 (2007).
Han, Y. and Lee, J. H. : Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol. Pharm. Bull. 28, 541 (2005).
Han, Y. : Synergic anticandidal effect of epigallocatechin-Ogallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol. Pharm. Bull. 30, 1693 (2007).
Yin, F., Li, L., Chen, Y., Lu, T., Li, W., Cai, B. and Yin, W. : Quality control of processed Crataegi Fructus and its medicinal parts by ultra high performance liquid chromatography with electrospray ionization tandem mass spectrometry. J. Sep. Sci. 38, 2630 (2015).
Lee, J. H., Park, J. H., Kim, Y. S. and Han, Y. : Chlorogenic acid, a polyphenolic compound, treats mice with septic arthritis caused by Candida albicans. Int. Immunopharmacol. 8, 1681 (2008).
Islam, S., Singer, M. and Kulhanjian J. A. : Toxic epidermal necrolysis in a neonate receiving fluconazole. J. Perinatol. 34, 792 (2014).
Egunsola, O., Adefurin, A., Fakis, A., Jacqz-Aigrain, E., Choonara, I. and Sammons, H. : Safety of fluconazole in paediatrics: a systematic review. Eur. J. Clin. Pharmacol. 69, 1211 (2013).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.